Influence of the Stereoisomeric Position of the Reactive Acetate Groups of the Benzo[b]Acronycine derivative S23906-1 on Its DNA Alkylation, Helix-Opening, Cytotoxic, and Antitumor Activities
Authors:
- Thomas GaslondeTGThomas Gaslonde
- Stéphane LéonceSLStéphane Léonce
- Laurence Kraus-BerthierLKLaurence Kraus-Berthier
- William LaineWLWilliam Laine
- Gaëlle LengletGLGaëlle Lenglet
- Angèle ChiaroniACAngèle Chiaroni
- Bruno PfeifferBPBruno Pfeiffer
- Sylvie MichelSMSylvie Michel
- François TillequinFTFrançois Tillequin
- Alain PierréAPAlain Pierré
Open Access
- 1 December 2009
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 76 (6) , 1172-1185
Abstract
S23906-1 is a benzo[b]acronycine derivative acting as a DNA-alkylating agent through covalent bonding to the exocyclic amino group of guanines and subsequent local opening of the DNA helix. This compound was selected for phase I clinical trials based on its efficient antitumor activity in experimental models and its unique mode of action. S23906-1 is the racemate of cis-1,2-diacetoxy-6-methoxy-3,3,14-trimethyl-1,2,3,14-tetrahydro-7H-benzo[b]pyrano[3,2-h]acridin-7-one. Here, we evaluated the cytotoxic and antitumor activities of the two pure cis-enantiomers and investigated the mechanism of action of both cis- and trans-racemates and their enantiomers in terms of DNA alkylation potency and locally drug-induced DNA helix opening process. Reaction with glutathione, as a detoxification process, was also studied. The trans-compounds, both as racemate or separated enantiomers, were found less potent than the corresponding cis-derivatives. Among the cis-enantiomers, the most efficient one regarding DNA alkylation bears the acetate on the reactive C1 position in the R configuration, both on purified DNA and genomic DNA extracted from cell cultures. By contrast, the most cytotoxic and tumor-active enantiomer bears the C1-acetate in the S configuration. Distinct cellular DNA-alkylation levels or covalent bonding to glutathione could not explain the differences. However, we showed that the S and R orientations of the acetate on C1 asymmetric carbon lead to different local opening of the DNA, as visualized using nuclease S1 mapping. These different interactions could lead to modulated DNA-repair, protein/DNA interaction, and apoptosis processes.Keywords
This publication has 35 references indexed in Scilit:
- The Sequence Dependence of Human Nucleotide Excision Repair Efficiencies of Benzo[a]pyrene-derived DNA Lesions: Insights into the Structural Factors that Favor Dual IncisionsJournal of Molecular Biology, 2009
- Differential Nucleotide Excision Repair Susceptibility of Bulky DNA Adducts in Different Sequence Contexts: Hierarchies of Recognition SignalsJournal of Molecular Biology, 2009
- The human DNA repair factor XPC‐HR23B distinguishes stereoisomeric benzo[a]pyrenyl‐DNA lesionsThe EMBO Journal, 2007
- Exocyclic amino groups of flanking guanines govern sequence-dependent adduct conformations and local structural distortions for minor groove-aligned benzo[a]pyrenyl-guanine lesions in a GG mutation hotspot contextNucleic Acids Research, 2007
- Poor base stacking at DNA lesions may initiate recognition by many repair proteinsDNA Repair, 2006
- Binding Discrimination of MutS to a Set of Lesions and Compound Lesions (Base Damage and Mismatch) Reveals Its Potential Role as a Cisplatin-damaged DNA Sensing ProteinJournal of Biological Chemistry, 2003
- Pharmacogenetics of Warfarin Elimination and its Clinical ImplicationsClinical Pharmacokinetics, 2001
- NMR Solution Structure of a DNA Dodecamer Duplex Containing a cis-Diammineplatinum(II) d(GpG) Intrastrand Cross-Link, the Major Adduct of the Anticancer Drug CisplatinBiochemistry, 1998
- DNA Sequence- and Structure-Selective Alkylation of Guanine N2 in the DNA Minor Groove by Ecteinascidin 743, a Potent Antitumor Compound from the Caribbean Tunicate Ecteinascidia turbinataBiochemistry, 1996
- HMG Domain Proteins Induce Sharp Bends in Cisplatin-Modified DNABiochemistry, 1994